Registration is open for the 2024 ASRM Scientific Congress & Expo
We thank the investigators for sharing their innovative approach to managing cesarean scar ectopic pregnancy (CSEP) (1). As they state, there is no high-quality evidence on the best treatment
Ovarian tissue cryopreservation (OTC) is increasingly offered globally as a fertility preservation strategy for both postpubertal women and prepubertal girls, with subsequent reimplantation of
Multiple underlying mechanisms often link obesity and metabolic syndrome conditions, which are associated with poorer reproductive outcomes (1–3). Women with obesity and unexplained infertility
Carrier screening in reproductive medicine is aimed at detecting deoxyribonucleic acid variants that are linked to a recessive genetic disease. Done before or during pregnancy, couples and
On behalf of the American Society for Reproductive Medicine (ASRM) Practice Committee, we would like to thank Dr. Orvieto for his insightful comments in response to the recently published ASRM
To evaluate differences in reproductive and neonatal outcomes on the basis of the time interval from cesarean delivery to subsequent frozen embryo transfer (FET).
To present the laparoscopic management of heterotopic cesarean scar pregnancy and discuss other treatment options.
On February 16, 2024, in the course of deciding LePage v. Mobile Infirmary Clinic, the Supreme Court of Alabama held that the State’s Wrongful Death of a Minor Act “applies to all unborn children
To investigate the efficacy of elagolix plus add-back therapy (estradiol [1 mg] and norethindrone acetate [0.5 mg] once daily) on patient-reported nonbleeding symptoms and menstrual bleeding
To compare the percentage of patients per race and ethnicity group in the most cited reproductive endocrinology and infertility studies with the most cited studies in 3 other obstetrics and
Displaying 251 to 260 of 1651 records